Form 4 for HBIO HARVARD BIOSCIENCE INC
Accepted 2024-06-14 00:00:00 ET · period of report 2024-06-13 · accession 0000921895-24-001418 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-06-14 | 2024-06-13 | HBIO | Green James W | CEO, Dir | P - Purchase | $2.91 | +10.0K | 3.11M | +0.3% | +$29.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-13 | P | A | 10,000 | $2.91 | 3,111,091 | D | — | — | (F1) Includes (a) 235,427 RSUs that will vest in two equal installments on December 29, 2024 and 2025, (b) 52,346 RSUs that will vest on December 29, 2024, (c) 214,797 RSUs that will vest in three equal installments on March 19, 2025, 2026 and 2027, (d) 699,772 RSUs with performance based vesting conditions and (e) 1,908,749 shares of common stock beneficially owned by the Reporting Person. |